As of 2025-06-24, the EV/EBITDA ratio of iNtRON Biotechnology Inc (048530.KQ) is -30.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 048530.KQ's latest enterprise value is 93,565.75 mil KRW. 048530.KQ's TTM EBITDA according to its financial statements is -3,044.56 mil KRW. Dividing these 2 quantities gives us the above 048530.KQ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 31.1x - 45.4x | 34.2x |
| Forward P/E multiples | 24.2x - 25.9x | 25.3x |
| Fair Price | (1,595.71) - 1,858.69 | (16.02) |
| Upside | -140.8% - -52.5% | -100.4% |
| Date | EV/EBITDA |
| 2025-06-19 | -31.12 |
| 2025-06-18 | -32.25 |
| 2025-06-17 | -32.02 |
| 2025-06-16 | -33.20 |
| 2025-06-13 | -34.04 |
| 2025-06-12 | -35.61 |
| 2025-06-11 | -36.12 |
| 2025-06-10 | -35.44 |
| 2025-06-09 | -35.67 |
| 2025-06-05 | -35.16 |
| 2025-06-04 | -35.84 |
| 2025-06-02 | -35.56 |
| 2025-05-30 | -35.95 |
| 2025-05-29 | -32.25 |
| 2025-05-28 | -32.36 |
| 2025-05-27 | -32.25 |
| 2025-05-26 | -33.37 |
| 2025-05-23 | -32.70 |
| 2025-05-22 | -33.37 |
| 2025-05-21 | -31.12 |
| 2025-05-20 | -29.67 |
| 2025-05-19 | -30.62 |
| 2025-05-16 | -29.72 |
| 2025-05-15 | -31.29 |
| 2025-05-14 | -31.69 |
| 2025-05-13 | -31.69 |
| 2025-05-12 | -31.85 |
| 2025-05-09 | -32.02 |
| 2025-05-08 | -32.08 |
| 2025-05-07 | -31.57 |
| 2025-05-02 | -31.80 |
| 2025-04-30 | -32.81 |
| 2025-04-29 | -33.26 |
| 2025-04-28 | -32.58 |
| 2025-04-25 | -33.54 |
| 2025-04-24 | -33.87 |
| 2025-04-23 | -35.05 |
| 2025-04-22 | -33.59 |
| 2025-04-21 | -33.20 |
| 2025-04-18 | -32.58 |
| 2025-04-17 | -32.58 |
| 2025-04-16 | -32.81 |
| 2025-04-15 | -33.59 |
| 2025-04-14 | -32.58 |
| 2025-04-11 | -31.97 |
| 2025-04-10 | -29.44 |
| 2025-04-09 | -26.92 |
| 2025-04-08 | -27.20 |
| 2025-04-07 | -27.42 |
| 2025-04-04 | -28.66 |